InsiderSignal.AI

InsiderSignal.ai

ANIX - Anixa Biosciences Inc

Insider Purchase by Baskies Arnold M (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

3 weeks ago, Baskies Arnold M, serving as Dir at Anixa Biosciences Inc (ANIX), purchased 10,000 shares at $3.04 per share, for a total transaction value of $30,400.00. Following this transaction, Baskies Arnold M now holds 135,000 shares of ANIX.

This purchase represents a 8.00% increase in Baskies Arnold M's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, January 28, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, January 29, 2026, 1 day after the trade was made.

Anixa Biosciences Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Baskies Arnold M

Dir

Dr. Arnold M. Baskies is an independent Director at Anixa Biosciences, Inc. (ANIX), serving since September 2018 (previously August 2016–September 2017), where he chairs the Nominating & Corporate Governance Committee and serves on the Audit and Compensation Committees.[[1]](https://fintool.com/app/research/companies/ANIX/people/arnold-baskies)[[2]](https://www.anixa.com/about/board-of-directors/bio/556/arnold-baskies-md)[[3]](https://ir.anixa.com/board-of-directors) A fellowship-trained surgical oncologist affiliated with Virtua Health Systems (NJ) and Clinical Professor of Surgery at Rowan School of Medicine, he specializes in breast, GI, thyroid, melanoma, and parathyroid cancers, and has co-investigated national breast cancer prevention studies.[[1]](https://fintool.com/app/research/companies/ANIX/people/arnold-baskies)[[2]](https://www.anixa.com/about/board-of-directors/bio/556/arnold-baskies-md)[[7]](https://www.anixa.com/about/cancer-business-advisory-board/bio/1030/arnold-baskies-md-facs) Dr. Baskies earned his B.A. summa cum laude and Phi Beta Kappa membership from Boston University (1971) and M.D. from Boston University School of Medicine (1975), completing surgical residency at Boston Medical Center and fellowship in surgical oncology at the National Cancer Institute.[[1]](https://fintool.com/app/research/companies/ANIX/people/arnold-baskies)[[2]](https://www.anixa.com/about/board-of-directors/bio/556/arnold-baskies-md)[[3]](https://ir.anixa.com/board-of-directors) His career highlights include serving as Chairman of the National Board of Directors of the American Cancer Society (2017), first Board Scientific Officer (2015), and leadership in global cancer control initiatives such as the WHO Global Breast Cancer Initiative; he also chaired the NJ Governor’s Task Force on Cancer (2000–2016).[[1]](https://fintool.com/app/research/companies/ANIX/people/arnold-baskies)[[8]](https://www.biospace.com/anixa-biosciences-congratulates-director-dr-arnold-baskies-for-his-appointment-to-the-who-s-global-breast-cancer-initiative) Recently, as ANIX Director, he purchased 10,000 shares on January 28, 2026, at $3.04 (total direct holdings: 135,000 shares) and 5,000 shares on July 18, 2025, at $3.39.[[5]](https://www.stocktitan.net/sec-filings/ANIX/form-4-anixa-biosciences-inc-insider-trading-activity-f866d14033fa.html)[[6]](https://www.tradingview.com/news/tradingview:0dda288f4913b:0-anixa-biosciences-director-arnold-m-baskies-acquires-5-000-shares/)

View full insider profile →

Trade Price

$3.04

Quantity

10,000

Total Value

$30,400.00

Shares Owned

135,000

Trade Date

Wednesday, January 28, 2026

25 days ago

SEC Filing Date

Thursday, January 29, 2026

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Anixa Biosciences Inc

Company Overview

No company information available
View news mentioning ANIX

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/3521405

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime